2020 Annual Meeting | N2 - Neuroscience in the Clinic: Multimodal Tools for Cardiac Arrest Neuroprognostication

Date Monday 04/27/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) H. E. Hinson, MD, MCR, FAAN, Martinson K. Arnan, MD, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants will be able to summarize the pros and cons of utilizing emerging biomarkers and tools for cardiac arrest prognostication and integrate this knowledge into their personal approaches for predicting post-arrest outcomes

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:05 PM	Introduction	Introduction Martinson K. Arnan, MD, FAAN
01:05 PM - 01:15 PM	Speaker	Case Presentation Sachin Agarwal, MD, MPH
01:15 PM - 01:55 PM	Speaker	Current Clinical Algorithms for Neurologists Approaching the Cardiac Arrest Patient Karen Hirsch, MD
01:55 PM - 02:20 PM	Speaker	Case Presentation: Follow Up Sachin Agarwal, MD, MPH
02:20 PM - 02:35 PM	Abstract	001 - Invasive neuromonitoring predicts awakening after diffuse hypoxic ischemic brain injury Swarna Rajagopalan, MD
02:35 PM - 02:50 PM	Abstract	002 - Resting EEG Spectral Features Related to Cortico-thalamic Integrity in Post-cardiac Arrest Patients Correlate with Outcomes Kurt Y. Qing, MD, PhD
02:50 PM - 03:00 PM	Closing Remarks	Summary of Discussion and Questions and Answers H. E. Hinson, MD, MCR, FAAN

Faculty Disclosures
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid AI. Dr. Hinson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Martinson K. Arnan, MD, FAAN	Dr. Arnan has nothing to disclose.
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Karen Hirsch, MD	Dr. Hirsch has nothing to disclose.
Peter B. Forgacs, MD	Dr. Forgacs has received personal compensation for serving as an employee of OVID Therapeutics Inc. Dr. Forgacs has received stock or an ownership interest from OVID Therapeutics Inc.
Swarna Rajagopalan, MD	Dr. Rajagopalan has nothing to disclose.
Nicholas D. Schiff, MD	Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Matthew Kirschen, MD, PhD, FAAN	The institution of Dr. Kirschen has received research support from NIH.
	No disclosure on file
Kurt Y. Qing, MD, PhD	Dr. Qing has nothing to disclose.
Ram Balu, MD	Dr. Balu has nothing to disclose.
Ryka Sehgal, MD	Ms. Sehgal has nothing to disclose.

��ɫ��

��ɫ��